Electronics company Royal Philips Electronics (Amsterdam, The Netherlands) and EP MedSystems, Inc. (West Berlin, NJ, U.S.), which develops and markets cardiac electrophysiology (EP) products used to diagnose and treat cardiac rhythm disorders, has formed an alliance to address what the companies say is an increasing need for a comprehensive electrophysiology (EP) lab solution for the diagnosis and treatment of cardiac rhythm disorders.
The agreement combines Philips’ cardiovascular X-ray technology with EP MedSystems' EP recording and data management systems.
The companies say that by combining Philips Allura X-ray imaging system with "superior signal quality of the EP-WorkMate(R) recording, stimulation, and mapping platform, EP MedSystems and Philips will offer electrophysiology solutions that will increase the overall effectiveness of patient procedures by enhancing present EP capabilities."
Products from the collaboration will initially be available in the U.S with the global cardiovascular market to follow.
Cardiac EP evaluates the electrical system of the heart and is mainly concerned with studying the cause and treatment of abnormalities in the heart's rhythm, which are called arrhythmias. Cardiac arrhythmias are caused by disturbances in the electrical activation of the heart muscle that ultimately cause the heart to pump less efficiently.
Cardiac rhythm disorders result in more than 1.2 million hospitalizations and 400,000 deaths each year in the United States, and account for about 20 percent of all chronic heart conditions, according to a MedSystems press release. These conditions are diagnosed and treated by electrophysiologists and cardiologists who specialize in the diagnosis and treatment of these cardiac arrhythmias.
Back to Breaking News